SCHEMBL18801255

SCHEMBL18801255

c1ccc(-c2cc(-c3ccccc3)nc(-c3cccc(-c4c5ccccc5c(-c5ccc6ccccc6c5)c5ccccc45)c3)n2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.55
CYP1B1 Q16678 1/20 0.55
MEN1 O00255 6/20 0.49
KMT2A Q03164 6/20 0.49
ALDH1A1 P00352 5/20 0.49
HPGD P15428 4/20 0.49
MAPT P10636 3/20 0.49
KDM4E B2RXH2 3/20 0.49
LMNA P02545 2/20 0.49
NTSR1 P30989 1/20 0.47
CYP1A2 P05177 2/20 0.46
GLA P06280 1/20 0.45
CTRC Q99895 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TP53 P04637 1/20 0.43
HSD17B10 Q99714 1/20 0.43
ESR1 P03372 2/20 0.41
ESR2 Q92731 2/20 0.41
MAOA P21397 2/20 0.41
MAOB P27338 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19650735 0.96 CYP1A1 (0.55) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL23784968 0.94 CYP1A1 (0.50) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL10301033 0.92 CYP1A1 (0.54) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL971934 0.92 CYP1A1 (0.57) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL19130627 0.92 CYP1A1 (0.48) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL17013940 0.92 CYP1A1 (0.48) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL973879 0.91 CYP1A1 (0.55) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL17013900 0.91 ALDH1A1 (0.47) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL22766805 0.90 MEN1 (0.49) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL22766656 0.90 MEN1 (0.49) CYP1A1CYP1B1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170207395-A1 ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2017-07-20 US disclosed
US-20170207395-A1 ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2017-07-20 US disclosed
EP-3163644-A1 ORGANIC ELECTROLUMINESCENT ELEMENT Hodogaya Chemical Co., Ltd. (JP) 2017-05-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170207395-A1 ORGANIC ELECTROLUMINESCENT DEVICE KCNN2, SLC7A5, KCNH3 CYP1A1 517/4885CYP1B1 990/4885MEN1 1671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.